No abstract available
Keywords:
immune checkpoint inhibitors; ipilimumab; nivolumab; parathyroid carcinoma; pembrolizumab.
Publication types
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Antineoplastic Agents, Immunological*
-
Humans
-
Lymph Nodes
-
Lymphatic Metastasis
-
Nivolumab
-
Parathyroid Neoplasms*
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab